The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

被引：0
|
作者：
Bushell, A. [1 ]
van der Net, J. [1 ,2 ]
Game, D.
Hilton, R. [3 ]
Thirkell, S. [4 ]
Friend, P. [2 ]
Geissler, E. [5 ]
Wood, K. [1 ]
Harden, P. [2 ]
Lombardi, G. [4 ]
机构：
[1] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford, England
[2] Oxford Transplant Ctr, Oxford, England
[3] Guys Hosp, London, England
[4] Kings Coll London, Guys Hosp, Immunoregulat Lab, London, England
[5] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D311
引用
收藏
页码：798 / 798
页数：1
相关论文
共 50 条
  • [21] Regulatory T-Cell Therapy in Transplantation and Severe Autoimmunity
    Rossetti, Maura
    Spreafico, Roberto
    CRITICAL REVIEWS IN IMMUNOLOGY, 2015, 35 (06) : 479 - 503
  • [22] Indirect allorecognition may activate regulatory cells in renal transplantation.
    Spadafora-Ferreira, M
    Caldas, C
    Fonseca, JA
    Kalil, J
    Coelho, V
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S54 - S54
  • [23] T REGULATORY CELL THERAPY TO CONTROL INFLAMMATION IN RENAL ALLOGRAFTS
    Vincenti, Flavio
    Tang, Qizhi
    Laszik, Zoltan
    Sarwal, Minnie
    Bluestone, Jeffrey
    Chandran, Sindhu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] REGULATORY T CELL MONITORING AND THE DEVELOPMENT OF CANCER POST RENAL TRANSPLANTATION
    Hope, C. M.
    Bergmann, I. P.
    Abeyaratne, A.
    Pilkington, K.
    Carroll, R. P.
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A25 - A25
  • [25] A safety and feasibility study of cell therapy in dilated cardiomyopathy
    Martino, H. F.
    Oliveira, P. S.
    Souza, F. C.
    Costa, P. C.
    Assuncao e Silva, E.
    Villela, R.
    Gaze, M.
    Weitzel, L. H.
    Oliveira, A., Jr.
    Muccillo, F. B.
    Arvelo, S. N. S.
    Sa, R.
    Guimaraes, T. C. F.
    Tura, B. R.
    Campos de Carvalho, A. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (10) : 989 - 995
  • [26] Antibody-mediated hypercoagulability in the anti-T-cell therapy of transplantation.
    Chen, JP
    Goldman, MH
    FASEB JOURNAL, 1998, 12 (05): : A902 - A902
  • [27] Renal transplantation and immunosuppressive therapy does not controindicate the possibility to be a stem cell donor for bone marrow transplantation.
    Amore, A
    Gaido, M
    Fagioli, F
    Saracco, P
    Coppo, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 376A - 376A
  • [28] Chimeric Antigen Receptor Regulatory T Cell in Transplantation: The Future of Cell Therapy?
    Lamarche, Caroline
    Maltzman, Jonathan S.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (06): : 1149 - 1152
  • [29] Regulatory T cells enhance the engraftment of subcutaneous islet transplantation.
    Izuwa, Aya
    Anazawa, Takayuki
    Yamane, Kei
    Emoto, Norio
    Su, Hang
    Kurahashi, Kouki
    Cui, Jialin
    Ito, Takashi
    Hatano, Etsuro
    TRANSPLANTATION, 2024, 108 (9S)
  • [30] Multicenter study of the safety and tolerability of basiliximab (Simulect®) in de novo pediatric renal transplantation.
    Offner, G
    Broyer, M
    Loirat, C
    Mentser, M
    Lemire, J
    Crocker, JFS
    Cochat, P
    Clark, G
    Hall, ML
    Korn, A
    Chodoff, L
    Mastropolo, A
    TRANSPLANTATION, 2000, 69 (08) : S258 - S259
12345